Compare EXPO & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPO | PBH |
|---|---|---|
| Founded | 1967 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 2.9B |
| IPO Year | 1990 | 2005 |
| Metric | EXPO | PBH |
|---|---|---|
| Price | $74.34 | $65.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $81.00 | ★ $86.40 |
| AVG Volume (30 Days) | 306.2K | ★ 337.3K |
| Earning Date | 02-05-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.03 | ★ 4.04 |
| Revenue | $531,142,000.00 | ★ $1,110,479,000.00 |
| Revenue This Year | $5.35 | N/A |
| Revenue Next Year | $7.90 | $2.50 |
| P/E Ratio | $36.58 | ★ $16.28 |
| Revenue Growth | ★ 4.43 | N/A |
| 52 Week Low | $63.81 | $57.25 |
| 52 Week High | $97.57 | $90.04 |
| Indicator | EXPO | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 54.26 | 59.18 |
| Support Level | $73.07 | $63.97 |
| Resistance Level | $74.94 | $68.28 |
| Average True Range (ATR) | 2.01 | 1.83 |
| MACD | 0.13 | 0.22 |
| Stochastic Oscillator | 67.35 | 65.86 |
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.